Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)

Full Show: Bloomberg Businessweek (05/26)
02:24 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • Full Show: Best of Bloomberg Technology (05/26)
  • Brown Brothers' Thin Favors Asia Over Latin America
  • The Sharing Economy's Entrepreneurial Ecosystems